Close
Help
Need Help?



DICOM Structured Reporting and Cancer Clinical Trials Results

Submit a Paper


LA Press Analytics


6375 Article Views

Publication Date: 12 May 2007

Journal: Cancer Informatics 2007:4 33-56

CI
journal

6,375 Article Views

2,566,680 LA Press Article Views

More Statistics

Abstract David A. Clunie

Abstract: The use of biomarkers derived from radiological images as surrogate end-points in therapeutic cancer clinical trials is well established. DICOM is the ubiquitous standard for the interchange of images for both clinical use as well as research. It also has capabilities for the exchange of image-related information, including categorical and quantitative information derived from images. The use of DICOM Structured Reporting for the encoding and interchange of clinical trial results in a standard manner is reviewed.


Post a Comment

x close

Discussion Add A Comment
No comments yet...Be the first to comment.


share on

Our Service Promise

  • Prompt Processing (Average 3 Weeks)
  • Fair & Constructive Peer Review
  • Professional Author Service
  • High Visibility
  • High Readership
  • What Our Authors Say

Quick Links

Follow Us We make it easy to find new research papers. RSS Feeds Email Alerts Twitter

BROWSE CATEGORIES
Our Testimonials
I had an excellent experience publishing our review article in Clinical Medicine Reviews.  The managing editor was very helpful and the process was very timely and transparent.
Professor Jonathan A. Bernstein (University of Cincinnati College of Medicine, Division of Immunology, Allergy Section, Cincinnati, OH, USA) What our authors say